Lumira Ventures collaborates with and invests in entrepreneurial management teams to build best-in-class, innovation-centric biotherapeutic and medical device companies that are meeting significant unmet needs and creating transformation impact in communities worldwide. Lumira executes a consistent, proven investment strategy as a lead investor and active partner with our portfolio companies. We focus on companies whose products offer transformative (not incremental) improvements to patient health outcomes, and the promise of dramatic reductions in the cost of healthcare delivery. Our Canadian heritage helps us “skate to where the puck is going to be,” investing in the new science and clinical insights that we expect will be driving the next decade of patient care.
Focus Investment
-Geography: Canada and U.S.
-Stage: Mix of early, clinical, and revenue stage companies that are both privately held and publically traded
-Sectors: Biotechnology, medical technologies, digital health, and consumer healthcare solutions
People
- Gerry Brunk, Managing Director
You last contacted this investor on .